Experimental identification and characterization of 97 novel npcRNA candidates in Salmonella enterica serovar Typhi by Chinni, Suresh V. et al.
Experimental identification and characterization
of 97 novel npcRNA candidates in Salmonella
enterica serovar Typhi
Suresh V. Chinni











1Institute of Experimental Pathology (ZMBE), University of Muenster, Von-Esmarch-Str. 56, 48149 Muenster,
Germany,
2Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia, 13200 Penang and
3Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Penang, Malaysia
Received March 13, 2009; Revised April 1, 2010; Accepted April 4, 2010
ABSTRACT
We experimentally identified and characterized 97
novel, non-protein-coding RNA candidates
(npcRNAs) from the human pathogen Salmonella
enterica serovar Typhi (hereafter referred to as
S. typhi). Three were specific to S. typhi, 22 were
restricted to Salmonella species and 33 were differ-
entially expressed during S. typhi growth. We also
identified Salmonella Pathogenicity Island-derived
npcRNAs that might be involved in regulatory mech-
anisms of virulence, antibiotic resistance and
pathogenic specificity of S. typhi. An in-depth char-
acterization of S. typhi StyR-3 npcRNA showed that
it specifically interacts with RamR, the transcrip-
tional repressor of the ramA gene, which is
involved in the multidrug resistance (MDR) of
Salmonella. StyR-3 interfered with RamR–DNA
binding activity and thus potentially plays a role in
regulating ramA gene expression, resulting in the
MDR phenotype. Our study also revealed a large
number of cis-encoded antisense npcRNA candi-
dates, supporting previous observations of global
sense–antisense regulatory networks in bacteria.
Finally, at least six of the npcRNA candidates inter-
acted with the S. typhi Hfq protein, supporting an
important role of Hfq in npcRNA networks. This
study points to novel functional npcRNA candidates
potentially involved in various regulatory roles
including the pathogenicity of S. typhi.
INTRODUCTION
Recent discoveries of a growing number of non-protein
coding RNAs (npcRNAs) in bacteria have challenged
the previous impression that proteins are the only
relevant players in the control of bacterial gene expression.
Bacterial small npcRNAs constitute a structurally diverse
class of molecules that are typically 50–200nt long and
play a crucial role in many cellular networks, including
responses to environmental stress, plasmid and viral rep-
lication, quorum sensing and bacterial virulence (1–9).
The majority of known bacterial npcRNAs regulate gene
expression by base pairing with mRNAs acting in trans- or
cis-, and thereby either activating or repressing translation
eﬃciency or the stability of the mRNA targets. Another
subclass of cis-encoded riboregulators are located in the
50-untranslated regions (UTR) of mRNA and are termed
riboswitches (10), and facilitate feedback regulation at
the transcription/translation level, following structure
changes in the RNA in response to the binding of the
metabolites.
Salmonella is categorized under the family of
Enterobacteriaceae that includes the group of enteric
bacteria. Based on DNA sequences, the Salmonella
genus includes two species, S. enterica and S. bongori
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(>2500 serovars). Salmonella enterica serovar Typhi (here-
after referred to as S. typhi) is a Gram-negative,
human-speciﬁc pathogen causing enteric typhoid fever,
an acute life-threatening febrile illness that aﬀects the re-
ticuloendothelial system. According to the World Health
Organization, 16–33 million cases and 500000–600000
deaths are reported around the world annually. S. typhi
is characterized by its ﬂagellar H-antigen, its
lipopolysaccharidic O-antigen and its polysaccharide
capsular virulence antigen found at the surface of freshly
isolated strains.
The genome of S. typhi strain Ty2 was recently
sequenced (11). It has a single 4.8-Mb chromosome with
an average G+C content of  52% and encodes 4339 genes
of which more than 200 are functionally inactive. Unlike
the multidrug resistance (MDR) strain S. typhi CT18,
S. typhi Ty2 has no plasmids and is sensitive to antibiotics.
Comparisons of S. typhi isolates from around the globe
indicated that they are highly related and can be traced to
a single point of origin  30000–50000 years ago (12).
Only  10% of the core genes are not shared between
Escherichia coli and S. enterica, suggesting that they
most likely branched from a common ancestor over 100
million years ago (12). A genome comparison with the
S. typhi CT18 strain demonstrated a remarkable degree
of conservation; one of the more interesting diﬀerences
being an additional cluster of a few genes in Ty2 that
may be a novel Salmonella Pathogenicity Island (SPI)
(11). There are 10 SPIs (SPI-1–10) presently known in
the S. typhi genome, all of which are thought to be
involved in the virulence of the pathogen.
One of the key features of S. typhi is its restriction to
human hosts, which has inhibited direct studies of its
pathogenicity. Instead, much has been learned from com-
parative research with its close serovar, S. typhimurium
in the mouse model. A number of npcRNAs involved in
diﬀerent regulatory pathways were identiﬁed in
S. typhimurium, including SPI-1-derived InvR npcRNA.
Surprisingly, InvR is not functionally linked to SPI-1 se-
cretion or invasion pathways, but instead regulates the
expression of OmpD porin (13). Padalon-Brauch et al.
(14) identiﬁed and characterized 19 novel npcRNAs
encoded by genes in the SPIs of S. typhimurium that
possibly function in the pathogenicity of the bacterium.
Using high-throughput pyrosequencing, Sittka et al. (15)
detected 65 npcRNA candidates in S. typhimurium, many
of which are conserved in S. typhi and related pathogenic
enterobacterial species (16,17) and may function in
complex with the Hfq protein. A number of characterized,
trans-encoded RNAs in bacteria require the Sm-like RNA
chaperone Hfq for regulating the translation of their
mRNA targets. Hfq binds with high aﬃnity to OxyS,
DsrA, RprA, RyhB, Spot42, SgrS and other npcRNAs
identiﬁed in E. coli and is frequently required for both
their intracellular stability and interaction with target
mRNAs (18–20), either to activate or predominantly to
silence translation (21). Deletion of Hfq in S. typhimurium
attenuates its ability to infect mice and especially to
invade epithelial cells, indicating that Hfq and its
ribonucleoprotein particle (RNP) complexes are essential
for the virulence of the bacterium (5). Expression of Hfq is
also essential for the virulence of Shigella ﬂexneri (22).
Recently, the S. typhi transcriptome was analyzed using
Illumina-platform high-throughput sequencing, whereby
40 putative npcRNAs were identiﬁed (23); surprisingly,
only ﬁve of them were also found in common with those
in S. typhimurium (15,23). Transcriptome analyses also
revealed the presence of cis-encoded npcRNAs expressed
in antisense orientation to open reading frames (ORFs) of
bacterial genes (24–26). Although many of the reported
examples negatively regulate expression of the comple-
mentary mRNAs, some of them (like GadY) increase
the stability of the corresponding mRNAs (27).
To survey the population of npcRNAs in S. typhi,w e
generated a specialized cDNA library representing three
diﬀerent growth stages of the bacterium. We experimen-
tally identiﬁed and characterized many novel npcRNA
candidates. Their diﬀerential expression patterns were
compared with potential homologs in E. coli. Many of
the npcRNA candidates are restricted to Salmonella
species or to S. typhi and some of the npcRNA candidates
may be involved in the MDR of S. typhi.
MATERIALS AND METHODS
S. typhi culture conditions
S. typhi was cultured in Luria-Bertani medium (LB);
100ml of a clinical isolate of S. typhi from glycerol stock
was aseptically inoculated into 10ml of LB medium and
incubated overnight at 37 C with 220 rotations per
minute. LB medium (250ml) was then inoculated with a
2.5ml aliquot of the overnight culture. Cells were har-
vested during the lag phase (OD600 0.3–0.4), log phase
(OD600 0.6–0.7) and stationary phase (OD600 1.5). Total
RNA was extracted by Trizol reagent (Gibco BRL) ac-
cording to the manufacturer’s instructions.
cDNA library construction
To avoid unintended bias in our starting material, equal
amounts of total RNA (50mg) extracted from diﬀerent
growth stages of S. typhi were combined, size fractionated
(20–500nt) on 8% denaturing PAGE gels (7M urea,
1 TBE buﬀer) and passively eluted in 0.3M NaOAc
(pH 5.3) overnight at 4 C. Size-selected RNA was
ethanol precipitated. All further steps of library construc-
tion were performed as described by Raabe et al. (28). The
resulting 1700 cDNA clones were randomly sequenced
and assembled into contigs. All cDNAs shorter then
18nt were excluded from further analysis. The resulting
388 contigs were manually analyzed and mapped to the
S. typhi Ty2 genome (AE014613) using BLAST (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) and BLAT (http://
archaea.ucsc.edu/cgi-bin/hgBlat) genomic browsers.
Northern blot analysis
Total RNA (8–10mg) was separated on 8% denaturing
polyacrylamide gels and electro-transferred onto
positively charged nylon membranes (Ambion Ltd).
Northern blot analyses using speciﬁc oligonucleotides
5894 Nucleic Acids Research, 2010,Vol.38, No. 17(Supplementary Table S1) complimentary to putative
npcRNAs were performed as described by Khanam
et al. (29).
Cloning and puriﬁcation of recombinant RamR and Hfq
proteins from S. typhi
DNA fragments representing the ORFs of ramR and hfq
protein-coding genes from S. typhi were generated by PCR
ampliﬁcation of genomic DNA. The reaction was per-
formed using a standard protocol (30), and oligonucleo-
tides RamRndeIF and RamRxhoIR (for ramR), and
HfqforvndeI and HfqrevxhoI (for hfq) (Supplementary
Table S1). To facilitate cloning, NdeI and XhoI restriction
sites were introduced into the oligonucleotide sequence.
The pET28-b+vector was used for cloning and expression
of RamR and Hfq proteins. The expected clones were
conﬁrmed by sequence analysis. The recombinant RamR
and Hfq proteins were puriﬁed from E. coli BL21 cells as
instructed by the manufacturer (Qiagen). The proteins
were dialyzed against buﬀer containing 20mM HEPES–
KOH (pH 7.4), 150mM KCl, 1.5mM MgCl2 and 5%
glycerol.
RNA gel shift assay
For binding assays to RamR or Hfq protein, S. typhi
novel npcRNA candidates were in vitro-transcribed from
PCR templates containing a T7 promoter using 250 U of
T7 RNA polymerase, and gel-puriﬁed npcRNAs were
radioactively labeled by incorporating [a-
32P] UTP
during the in vitro transcription. Before incubating with
recombinant RamR or Hfq protein, RNAs were dissolved
in buﬀer containing 20mM HEPES-KOH (pH 7.4),
80mM NaCl, 10mM KCl, 2.5mM MgCl2, heat-
denatured (2min at 85 C) and subsequently placed in
ice. RNP complexes of recombinant RamR or Hfq
proteins with npcRNAs were formed in reaction
volumes of 20ml containing 20mM HEPES–KOH
(pH 7.4), 80mM NaCl, 10mM KCl, 2.5mM MgCl2,
2mM DTT, 10% glycerol, 1mg BSA, 5mg tRNA and
5 U of ribonuclease inhibitor (RNasin, Fermentas); 2mg
of sheared salmon sperm DNA was added for the RamR
protein binding assay. Aliquots (0.05 pmol) of npcRNAs
were incubated with increasing concentrations of RamR
or Hfq for 30min at room temperature. RNA and RNA–
protein complexes were separated on native 8% (w/v)
polyacrylamide gels containing 1 TBE (90mM Tris;
64.6mM boric acid; 2.5mM EDTA; pH 8.3). All further
steps were performed as described by Rozhdestvensky
et al. (31). The apparent K50 values of the RNA–
protein complexes were deﬁned as the protein concentra-
tions for which 50% of the input RNA was shifted to an
RNP complex.
DNA gel shift assay
For binding assays to RamR protein, two complementary
60-nt oligonucleotides harboring the promoter region
of the S. typhi ramA gene were synthesized (MWG
Biotech, Ebersberg, Germany) (Figure 3A;
Supplementary Table S1). As controls, oligonucleotides
harboring 9-nt and 2-nt deletions were also generated
(Figure 3A, Supplementary Table S1; 32,33).
Complementary single-stranded DNA fragments were
end-labeled with [g-
32P]-ATP using T4 polynucleotide
kinase and annealed. The resulting double-stranded
DNA fragments were gel-puriﬁed from native 10% (w/v)
polyacrylamide gels containing 1 TBE and passively
eluted in 0.3M NaOAc (pH 7.0) and 1mM EDTA
buﬀer at 4 C overnight.
Complexes of recombinant RamR protein with DNA
fragments ( 0.05 pmol per reaction) were formed in a
volume of 20ml containing 20mM HEPES–KOH (pH
7.4), 80mM NaCl, 10mM KCl, 2.5mM MgCl2,2 m M
DTT, 10% glycerol, 1mg BSA, 5mg tRNA, 2mgo f
sheared salmon sperm DNA and 5 U of ribonuclease in-
hibitor (RNasin, Fermentas) (Figure 3B). The subsequent
steps were performed as described above for RNA gel shift
assays.
Gel shift competition assays
Competition assays were performed under the above
binding conditions with 300nM RamR protein and
increasing concentrations of DNA fragments or S. typhi
StyR-3 npcRNA as competitors (Figure 3D). All reactions
were incubated for 30min at room temperature. DNA and
DNA-protein complexes were separated on native 10%
(w/v) polyacrylamide gels containing 1 TBE buﬀer.
Electrophoresis and subsequent steps were performed as
described above.
Oligonucleotides used in this work
All oligonucleotides used in this work are listed in
Supplementary Table S1.
RESULTS AND DISCUSSION
cDNA library construction and analysis
To survey the population of npcRNAs in S. typhi,w e
generated a specialized cDNA library representing the
lag, log and stationary growth stages of the bacterium.
A total of 1700 cDNA clones were randomly sequenced
and assembled into contigs. All cDNAs shorter than 18nt
were excluded from further analysis. The resulting 388
contigs were manually analyzed and mapped to the
S. typhi Ty2 genome (AE014613) using BLAST (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) and BLAT (http://
archaea.ucsc.edu/cgi-bin/hgBlat) genomic browsers. To
identify known npcRNAs in our data set, we screened
cDNA sequences against known npcRNAs in Salmonella
and E. coli. Nearly half of the cDNAs were derived from
the highly abundant npcRNA species of rRNAs (22%)
and tRNAs (25%) (Figure 1A). Roughly 5% of the
cDNA sequences belonged to other known npcRNAs
(Supplementary Table S3). cDNAs that mapped to the
ORFs of known or hypothetical protein-coding genes
constituted the largest subgroup (27%). Some of these
cDNAs might represent potential npcRNA species that
overlap with ORFs, similar to RNAIII, a small
npcRNA in S. aureus (34). Moreover, the predicted
ORFs of the hypothetical protein-coding genes matching
Nucleic Acids Research, 2010,Vol.38, No. 17 5895some of the cDNAs may be wrongly annotated and may
encode potential novel npcRNAs instead (Supplementary
Table S2). Furthermore, some of those candidates overlap
with putative 50-UTR regions and may represent the
products of transcriptional attenuation and correspond
to potential candidates for novel riboswitches
(Supplementary Table S2).
Interestingly, 21% of the cDNAs could not be assigned
to any known RNAs, and thus represent candidates for
novel npcRNAs in S. typhi (Figure 1A and B). Eight of
these 97 npcRNA candidates overlap with those identiﬁed
by Perkins et al. (23) via deep sequencing. As mentioned
above, deep sequencing approaches in the closely related
S. typhimurium and S. typhi species also revealed only 5
putative npcRNAs in common (15,23). Such a paucity of
overlap was also observed in our laboratory in another
instance where two diﬀerent sequencing approaches were
available for the same or similar RNA preparations (our
unpublished data). Most likely, the diﬀerences are a con-
sequence of alternative methodologies for preparing
RNAs for cDNA libraries and for sequencing (e.g.
pre-selections, tailing, linker ligation and PCR ampliﬁca-
tion). Hence, comparisons between two data sets are valid
only when generated with virtually identical experimental
approaches. These observations are a clear warning that
even deep sequencing is unlikely to represent all RNA
species, the identiﬁcation of which may require a combin-
ation of various approaches.
Potential candidates for novel npcRNAs in S. typhi
The 97 npcRNA candidates that we identiﬁed experi-
mentally (Figure 1B) have been assigned reference
identiﬁcations based on the template, StyR-n (S. typhi
npcRNA - number). Three of the npcRNA candidates
are speciﬁc to S. typhi and 22 are restricted to
Salmonella species; of these three are restricted to
S. typhi and S. paratyphi C and one to S. typhi and
S. paratyphi A. Most of our npcRNA candidates are
transcribed complimentarily to ORFs of known or hypo-
thetical protein-coding genes (39 candidates, Figure 1B),
supporting previous experimental evidence of signiﬁcant
antisense transcription in bacteria (35,36). Twenty-four
npcRNA candidates were mapped to intergenic regions
of the S. typhi genome (Figure 1B). Given that most
known npcRNAs in bacteria were previously identiﬁed
and characterized in E. coli and the close phylogenetic
relationship between S. typhi and E. coli (60–70%
genomic similarity), we computationally predicted the
existence of 63 putative homologous and novel
npcRNAs that we designated as EcoR (Escherichia coli
npcRNA- number).
Expression analysis of novel StyR npcRNAs
To determine the diﬀerential expression of our npcRNA
candidates and to validate our computational analysis, we
performed northern blot hybridizations on total RNA
samples from three diﬀerent bacterial growth stages. To
ensure speciﬁc detection of npcRNA candidates, we
designed a second oligonucleotide probe complementary
to the respective RNA sequence in most of the cases
(Supplementary Table S1). Approximately 45% of the
npcRNA candidates were detected on northern blots
(Figure 1B). Many of these transcripts exhibited the
same length as the corresponding cDNA sequence
contigs, leading us to conclude that our technique for con-
structing the bacterial cDNA library often yields
full-length npcRNAs. However, in a few cases, the result-
ing northern blot signals suggested longer RNAs than the
cDNAs predicted. Diﬀerential expression analyses of the
npcRNA candidates indicated that the majority of them
were regulated in a growth-dependent manner in S. typhi.
To conﬁrm the validity of the 63 putative npcRNAs
orthologs predicted in E. coli, we carried out northern
blot analysis with E. coli total RNA isolated from three
diﬀerent growth stages in parallel. Northern blot signals
supported the phylogenetic predictions for 19 of these
npcRNA homologs (Figures 2, 4, 5B and 6)
Based on their genomic localization and orientation, we
grouped the novel npcRNA candidates into four classes:
(i) intergenic npcRNAs; (ii) antisense npcRNAs; (iii) re-
petitive npcRNAs; and (iv) npcRNAs partially
overlapping with ORFs (Figure 1B). To a large degree,
however, these classiﬁcations were somewhat arbitrary,
chieﬂy due to incomplete annotations of the genome.
For example, with regard to the intergenic regions
(Class 1), there are no annotations for 50- and 30-UTRs,
because very few experimental data are available. An
intergenic RNA might simply be derived from a UTR
representing a more stable domain of an mRNA.
Furthermore, the promoter-associated npcRNAs (Class
1.1) and terminator-associated npcRNAs (Class 1.2) are,
strictly speaking, not intergenic and in many cases might
be more appropriately classiﬁed as 50- and 30-
UTR-associated or -derived RNAs, a deﬁnition that
97 novel S. typhi npcRNA candidates 
24 intergenic
(12 in E. coli)
39 antisense
(25 in E. coli)
11 repetitive
(8 in E. coli)
23 partially
ORF overlap

















Figure 1. Classiﬁcation of cDNA sequences and identiﬁed novel
npcRNA candidates. (A) Distribution of the cDNA sequences among
various classes of RNA species; frequencies indicated as percentages.
(B) Classiﬁcation and expression proﬁles of novel npcRNA candidates
in S. typhi and their E. coli homologs.
5896 Nucleic Acids Research, 2010,Vol.38, No. 17would also include riboswitches. The same diﬃculty arises
for npcRNAs that map between genes in an operon (Class
1.3). Only the individual genes (Class 1.4) may be truly
intergenic. On the other hand, npcRNAs located in a sense
or antisense orientation to hypothetical ORFs might also
be truly intergenic npcRNAs. The candidates located in a
sense orientation to ORFs are listed in Supplementary
Table S2 and are marked as being derived from hypothet-
ical ORFs to discriminate them from sense RNAs located
within proven ORFs, as the majority of the latter merely
represent more stable degradation products of bona ﬁde
mRNAs.
Class 1: novel npcRNA candidates from intergenic regions
of S. typhi
Obviously, intergenic regions remain the ‘hot spot’ for
computational searches of npcRNAs. In fact, a number
of previous predictions were focused solely on intergenic
regions of bacteria (37–39). However, the intergenic
npcRNA candidates that harbor low phylogenetic conser-
vation or do not encode conserved secondary structures
might not be detected in computational screens.
Moreover, in some cases, the criterion of sequence conser-
vation alone is insuﬃcient and could be misleading. This
might be particularly important for evolutionarily young
and probably species-speciﬁc npcRNAs that nevertheless
might exert important functions. Our experimental
approach uncovered 24 npcRNA candidates derived
from intergenic regions of S. typhi and the expressions
of 15 of them were monitored by northern blot analysis.
The corresponding RNAs range in size from 32 to 212nt
and many of them show growth stage-speciﬁc expression
(Figure 2). We identiﬁed putative transcriptional regula-
tory elements (promoters and r-independent terminators)
for ﬁve npcRNA genes from this category. However, their
transcriptions might be more complex and some might be
initiated from promoters of the adjacent genes. The
intergenic npcRNAs were further subdivided into four
categories depending on their location (Table 1).
Subclass 1.1: promoter-associated npcRNAs. The principle
of transcriptional interference, also termed promoter oc-
clusion, has been known for a long time in bacteria. It
describes the regulatory interplay between two neighbor-
ing promoters. Transcription initiated by the upstream
promoter inhibits transcriptional start of the downstream
promoter (40,41). Recently, the mechanisms of transcrip-
tional control involving small npcRNAs associated with
transcription start sites in higher eukaryotes were
described (42,43). In addition, there are reports indicating
regulation of promoter activity by npcRNAs in yeast
(44,45). Therefore, the control of transcription by
promoter-associated RNA transcripts might be of broad
importance.
We identiﬁed 12 npcRNA candidates that are
transcribed within conserved mRNA promoter regions.
In addition, ﬁve of the promoter-associated npcRNAs
contain putative transcription factor binding sites within
their primary sequences. Interestingly, there are reports
indicating that transcription factors other than those
with DNA binding activity also interact with RNA mol-
ecules (for review see 46). In this scenario, the npcRNA
involves not only cis-mediated promoter occlusion but
also regulates transcription in trans.
StyR-3 is an example of a promoter-associated
npcRNA candidate. The RNA is co-transcribed by the
promoter of the ramA gene and shares its putative tran-
scriptional start site (Figures 2 and 3A). StyR-3 is likely a
stable processing product derived from the RamA
50-UTR. StyR-3 represents an abundant npcRNA
species in our library, with 24 independent cDNAs. The
northern blot signal is consistent with a stable 144-nt
StyR-3 transcript (Figure 2).
RamA protein was recently identiﬁed as an alternative
global regulator and an activator of the MDR regulation
cascade in S. typhimurium. Overexpression of RamA was
associated with MDR also in Enterobacter aerogenes,
Klebsiella pneumonia and S. enterica serovar Paratyphi B
(47–49). Recent reports identiﬁed two deletions in the
promoter region of ramA that remarkably enhanced tran-
scription of ramA, and consequently the MDR of bacteria
(32,33). StyR-3 overlaps the location of these two dele-
tions, suggesting the presence of important suppressive
cis-acting elements within the region encoding the
StyR-3. In addition, two inverted repeats, one of them
overlapping with StyR-3, were predicted to be DNA
binding sites for the local repressor, RamR (Figure 3A;
32,33). RamR belongs to the TetR family of proteins and
inactivation of its gene in a susceptible serovar of the
Typhimurium strain resulted in an MDR phenotype (32).
Several transcription regulatory proteins interact both
with DNA and RNA (46). Hence, we investigated
whether the RamR transcriptional repressor protein spe-
ciﬁcally binds to StyR-3 npcRNA.
First, we conducted a gel retardation assay to examine
whether the predicted binding sites within the ramA
Figure 2. Expression analysis of intergenic-derived npcRNA candidates
at diﬀerent growth stages of S. typhi and E. coli. Northern blot analysis
was performed on total RNA isolated from S. typhi and E. coli cultures
at diﬀerent OD600 values, as shown across the top of the blots. OD600
0.3: lag phase-steady bacterial growth; OD600 0.7: log phase-exponential
bacterial growth; and OD600 1.5: stationary growth phase. The
npcRNA candidates and their sizes are indicated. As loading
controls, a few examples of ethidium bromide-stained 5S rRNA are
shown at the bottom of each panel.
Nucleic Acids Research, 2010,Vol.38, No. 17 5897regulatory region speciﬁcally interact with and form a
stable deoxyribonucleoprotein (DNP) complex with
RamR protein. The in vitro-synthesized DNA fragments
harboring the proposed RamR binding sites were radio-
actively labeled and a gel retardation assay was performed
using increasing concentrations of RamR protein (see
‘Material and Methods’ section; Figure 3B). We detected
formation of a stable DNP complex with an apparent K50
of 300nM (complex formation was performed in the
presence of vast excesses of non-speciﬁc DNA and RNA
competitors Figure 3B). To provide further evidence of the
speciﬁcity of RamR recognition, we assayed DNA frag-
ments harboring the aforementioned 2- and 9-bp deletions
within the ramA regulatory region. As expected, we did
not observe a mobility shift with mutant DNA when
incubated with increasing concentrations of RamR
protein (Figure 3B). The loss of complex formation is con-
sistent with overexpression of RamA and the MDR
phenotype observed in S. typhimurium mutant strains
(32,33).
Next, we examined via a gel retardation assay whether
StyR-3 is speciﬁcally recognized by and forms an RNP
complex with RamR protein. The in vitro binding assay
detected the formation of an StyR-3/RamR–RNP
complex with an apparent K50 of 300nM (again,
complex formation was done in the presence of vast
excesses of non-speciﬁc DNA and RNA competitors
Figure 3C). Thus, we demonstrated that RamR speciﬁc-
ally interacts with DNA harboring the regulatory region
for the ramA gene and with StyR-3 npcRNA. Moreover,
both DNP and RNP complexes were formed with similar
apparent K50 values (Figure 3B and C).
We therefore investigated whether StyR-3 interferes
with RamR-DNA binding activity using a competition
binding assay with increasing concentrations of unlabeled
StyR-3. Even low concentrations (1 pmol) of competing
StyR-3 abolished RamR–DNA binding (Figure 3D).
Notably, similar results were observed when increasing
concentrations of the same unlabeled wild-type DNA
were added (Figure 3D). In contrast, when we competed













Speciﬁcity Comments Acc. No.
Promoter-associated npcRNAs
StyR-3 144 <<> 1067322/1069368 No +/   /  Sal. sp FJ746361
StyR-8 94 >>> 1069235/1069233 Yes  /   /  FJ746362
StyR-10 147 <<> 1067006/1067023 Yes +/+ +/  FJ746363
StyR-88 109 >>> 1067919/1067920 Yes +/  +/  FJ746366
StyR-99 32 <>> 1067609/1068774 No  /   /  Sal. sp FJ746367
StyR-134 72 >>> 1069120/1069122 No  /   /  Sal. sp FJ746369
StyR-241 152 <<> 1068271/1068273 Yes +/+ +/+ r-ind. term. FJ746373
StyR-262 156 <>> 1069506/1069507 Yes  /   /  FJ746374
StyR-287 50 >>> 1067282/1069315 No  /   /  Sal. sp FJ746376
StyR-293 59 <>> 1070460/1070461 Yes  /   /  FJ746378
StyR-362 141 <>> 1070630/1070631 No  /   /  Sal. sp r-ind. term. FJ746382
StyR-383 22 <<> 1068808/1068821 No  /   /  Sal. sp FJ746384
Terminator-associated npcRNAs
StyR-169 32 <<< 1069647/1067454 Yes +/+ +/+ FJ746371
StyR-288 44 >>< 1070605/1070606 Yes +/+  /  FJ746377
Operon-derived npcRNAs
StyR-55 77 <<< 1068343/1071526 Yes +/+ +/+ FJ746364
StyR-126 34 <<< 1069335/1067249 Yes +/+ +/+ FJ746368
StyR-175 77 >>> 1069764/1069765 Yes +/+ +/+ FJ746372
StyR-280 102 <>> 1068036/1068041 Yes +/+ +/+ FJ746375
StyR-306 28 >>> 1071397/1071398 No +/  +/  FJ746379
StyR-333 40 <<< 1067027/1067676 No +/  +/  S. typhi FJ746380
StyR-354 46 <<< 1067015/1068236 No  /   /  Sal. sp FJ746381
Possible individual intergenic npcRNA genes
StyR-59 162 ><< 1068621/1068614 No +/   /  S. typhi r-ind. term. FJ746365
StyR-161 132 ><> 1068552/1069548 No +/  +/  S. typhi,
S. para C
r-ind. term. FJ746370




npcRNAs, reference identiﬁcations of npcRNA candidates; cDNA (nt), length of cDNAs in nt; Orient., orientation of npcRNA (middle arrow) and
adjacent genes (right and left arrows); Adj. Genes (ID), gene ID numbers of genes ﬂanking the npcRNA candidates; Presence in E. coli, npcRNA
homolog is present (Yes) or not present (No) in the E. coli K12 genome; N. blot S. typhi/E. coli, northern blots were positive (+) or negative ( ) for
the given npcRNAs; Growth reg. S. typhi/E. coli, npcRNA is (+) or is not ( ) growth phase-regulated in S. typhi/E. coli; Speciﬁcity, species speciﬁc;
Sal sp, Salmonella species speciﬁc; S. typhi, S. typhi speciﬁc; S. para C, npcRNA is present in S. paratyphi C; Comments: r-ind. term., probable
r-independent/intrinsic terminator detected; Acc. No., accession number of npcRNA sequence in DDBJ/EMBL/GenBank databases.
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fragments harboring the 9-bp deletion within the RamR
binding site, no competition was detected (data not
shown). Our data suggest an involvement of StyR-3 in
the regulation of RamR-DNA binding activity, which
might consequently eﬀect ramA gene expression and the
MDR of S. typhi. Given the obvious medical importance
of MDR, StyR-3 might be considered a potential drug
target.
We also identiﬁed other npcRNA candidates that
overlap with DNA binding sites for regulatory proteins:
StyR-88 with IscR, StyR-241 with Ntrc, StyR-293 with
FNR and StyR-287 with GadX (Figure 2; Supplementary
Figure S1). It will be interesting to examine whether these
npcRNA candidates are speciﬁcally recognized by and
form RNP complexes with the corresponding transcrip-
tion factors. Alternatively, these npcRNA candidates
may be involved in bacterial chromosome remodeling
and consequently regulate promoter activity in cis.
Subclass1.2:terminator-associatednpcRNAs. Terminator-
associated npcRNA candidates are a subclass of small
stable npcRNAs located in regions overlapping
r-independent terminator signals. The two candidates
of this class are transcribed in a sense orientation with
respect to the corresponding mRNAs and are likely
derived from their 30-UTRs. StyR-169 is associated
with the terminator of the hypothetical protein gene
yaiA, and StyR-288 overlaps with the r-independent ter-
minator signal of the putative-exported protein-coding
gene t0311 (Supplementary Figure S1). Northern blot
analyses revealed that StyR-169 (32nt) and StyR-288
(44nt) are generated from longer primary transcripts
that are subject to diﬀerential processing steps (Figure 2).
Subclass 1.3: operon-derived npcRNAs. This subgroup
consists of npcRNA candidates that do not contain dis-
cernible transcription regulatory elements, are possibly
transcribed as parts of operons, and undergo additional
RNA processing steps for maturation. Seven such
npcRNA candidates were identiﬁed and their expressions
conﬁrmed by northern blot hybridization. StyR-55
contains a sequence motif that is essential for translational
feedback regulation and eﬃcient translation of L10 and
L12 ribosomal protein-coding mRNA from the L10
operon (Figure 2; Supplementary Figure S1). Proteins
L10 and L12 form a complex that speciﬁcally interacts
(if rRNA binding sites are saturated) with the 50-leader
sequence of the L10 operon mRNA and prevents transla-
tion (50). StyR-55 harbors the unique binding site for the
Figure 3. Gel retardation analysis of the interaction of RamR protein with ramA gene regulatory region and StyR-3. (A) Sequence of ramA
regulatory region. The  35,  10 and RBS sequences are underlined. Predicted RamR–DNA binding sites are indicated with bold letters. The
2-bp (2 bp DNA) and 9-bp (9 bp DNA) deletions within the ramA regulatory region are boxed. The transcriptional start site is indicated by an
arrow. Asterisks indicate the 50- and 30-nt for the DNA fragment (WT DNA) used in the gel retardation assay. The StyR-3 sequence is indicated with
a dotted line. (B) Gel retardation analysis of the interaction of RamR protein with the ramA gene regulatory region, showing wild-type DNA
fragment (left), 2-bp (middle) and 9-bp (right) deletion fragments. (C) Interaction of RamR protein with StyR-3. (B and C) 32P-labeled DNA
fragments or StyR-3 were incubated with S. typhi recombinant protein RamR as follows: lane 1, no protein added; (B and C) lanes 2–8: 50, 100, 150,
200, 400, 600 and 800nM RamR protein was added, respectively; (D) Competition assay. 32P-labeled WT DNA was competed from RamR–DNP
complex with increasing concentrations of unlabeled StyR-3 (lanes 3–5: 50, 250 and 500nM, respectively) and WT DNA (lanes 6–8: 50, 250 and
500nM, respectively). DNA: competitor molar ratios for lanes 3 and 6; 4 and 7; 5 and 8 were: 1:20; 1:100 and 1:200, respectively.
Nucleic Acids Research, 2010,Vol.38, No. 17 5899inhibitory L10/L12 complex. Expression of this candidate
npcRNA was detected only in the stationary phase of
S. typhi growth (Figure 2). StyR-55, as an RNP with
L10/L12 proteins, might participate in regulation of the
L10 operon, be involved in a yet unknown function or
both. Similarly, in E. coli, the t44 npcRNA was recently
identiﬁed in an analogous region of the rps2 gene,
encoding ribosomal protein S2. The t44 npcRNA was
proposed to play a role in attenuating rps2 gene expression
(51). An additional novel npcRNA candidate from
S. typhi, StyR-8, originating from the leader sequence of
the rmpB gene encoding ribosomal protein L28, was
identiﬁed in our study (Supplementary Figure S1). This
ﬁnding might provide new insight into the regulation of
ribosomal protein-coding gene expression. Future experi-
mentation will determine whether, due to their stable
structures and bound proteins, such RNAs are simply
more stable degradation products of the transcribed
operons or true functional riboregulators.
Subclass 1.4: possible individual npcRNA genes. This
category contains npcRNA candidates that are
transcribed from intergenic regions of the S. typhi
genome and for which associated regulatory elements
(promoter and r-independent/intrinsic terminator) were
predicted computationally. However, the situation might
be more complex; for example, transcription might be
initiated from promoters of adjacent genes. Three such
npcRNA candidates were identiﬁed. Importantly, all of
them were restricted to Salmonella serovars, representing
evolutionarily young npcRNA species with potential
strain-speciﬁc functions (Table 1; Figure 2;
Supplementary Figure S1). Thus, StyR-381 is found in
S. typhi and S. dublin genomes; StyR-161 is present
in S. typhi and S paratyphi C; and StyR-59 is restricted
to S. typhi.
Class 2: Antisense S. typhi npcRNAs
Small antisense npcRNAs have been studied in bacteria
for over two decades and are classiﬁed according to their
location on either chromosomal or plasmid DNA.
Chromosomally encoded antisense npcRNAs are
involved in diverse bacterial regulatory pathways.
Generally, the functions of these RNAs are associated
with transcriptional attenuation, inhibition of translation,
or promotion of RNA degradation or cleavage (52,53).
Most of the chromosomally encoded antisense npcRNA
genes are expressed only under certain conditions, for
example, as gadY in a growth rate-dependent manner
(27) or as isrR under stress conditions (54). The antisense
npcRNAs are cis-encoded with perfect complementarity
to large stretches of the corresponding target RNAs.
We identiﬁed 39 npcRNAs candidates derived from the
strands of DNA complementary to protein-encoding
genes (i.e. cis-encoded). In fact, they constituted the
largest number of novel npcRNAs identiﬁed (Table 2).
Of these, 24 npcRNA candidates have homologs in
E. coli (Table 2) and 10 show growth stage-speciﬁc expres-
sion patterns in S. typhi (Figures 1B and 4). Based on their
location with respect to the ORF of the target genes, we
established four subcategories.
Subclass 2.1: npcRNA candidates antisense to the 30-end of
ORFs. Three of the antisense npcRNAs (StyR-143,
StyR-219 and StyR-250) partially overlap the 30-ends of
ORFs (Table 2; Supplementary Figure S2). The cis-anti-
sense candidate StyR-219 is complementary to the 30-part
of the ORF of prfB that encodes peptide chain release
factor-2 (Supplementary Figure S2). StyR-219 features a
r-independent/intrinsic terminator and is conserved in
many other enterobacteria. We computationally predicted
an E. coli K12 homolog (EcoR-219) that shares 89%
sequence similarity. Interestingly, the expression of the
E. coli prfB gene is upregulated during later growth
stages (55,56), whereas the expression of StyR-219 is
highest during the log phase of growth and expressions
of both the S. typhi and E. coli homologs are reduced as
the cultures reach their stationary phases (Figure 4).
Phylogenetic conservation and the reversely correlated ex-
pression proﬁles of npcRNA and mRNA strongly indicate
that StyR-219 is involved in regulation of prfB expression.
Subclass 2.2: npcRNA candidates antisense to the 50-end of
ORFs. The cis-encoded StyR-341 npcRNA candidate was
located complementary to the ribosomal binding site
(RBS) and translational start codon of the protein-coding
gene t2574, which is restricted to Salmonella species and
maps to SPI-6 (Figure 7; Supplementary Figure S2), sug-
gesting a function in S. typhi pathogenicity. In bacteria,
npcRNAs exhibiting complementarities to mRNA regions
involved in translation initiation, such as RBSs and AUG
start codons, are obvious candidates for control at the
level of translation regulation. Therefore, StyR-341
might be an example of a riboregulator that is associated
with virulence gene control.
Subclass 2.3: npcRNA candidates antisense to the 50- and 30-
ends of two diﬀerent ORFs. Two cis-encoded antisense
npcRNA candidates (StyR-150 and StyR-328) are
transcribed such that they are partially complementary
to the 50- and 30-ends of two neighboring ORFs, as well
as to the corresponding UTRs and the entire intergenic
region (Supplementary Figure S2). StyR-328 is comple-
mentary to the RBS plus AUG start codon of the fdhE
gene and the stop codon of the fdoI gene. Both
protein-coding genes are involved in formate metabolism.
In addition to molecular oxygen, Salmonella can utilize
formate dehydrogenase-O under aerobic conditions as
an alternative terminal electron acceptor to generate a
proton motive force (57). The physiological role of
formate dehydrogenase-O is to ensure rapid adaptation
during a sudden shift from aerobiosis to anaerobiosis to
compensate for low levels of formate dehydrogenase-N
(57). Formate dehydrogenase-O shares sequence similarity
and immunological properties with the anaerobically ex-
pressed formate dehydrogenase-N. StyR-328 might
possibly regulate bacterial adaptation to anaerobic condi-
tions. This might partially explain our failure to detect the
mature npcRNA during the examined growth stages of
S. typhi under aerobic conditions.
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complementary to ORFs. Thirty-one npcRNA candidates
belong to a subclass of cis-encoded antisense RNA species
that are complementary to internal parts of the ORFs of
known or hypothetical protein-coding genes (Table 2;
Supplementary Figure S2). StyR-243 (135nt) is expressed
in an antisense orientation to ORF of the oxyR gene,
which encodes a DNA binding, transcriptional dual regu-
lator of the LysR family (58). The gene encoding StyR-243
is highly conserved in all Salmonella species with a pre-
dicted putative homolog in E. coli (EcoR-243, 83%
sequence similarity). OxyR participates in controlling
several genes involved in the response to oxidative stress
and the production of surface proteins by activating the
expression of several genes (e.g. dps, fur and katG) whose
protein products regulate intracellular hydrogen peroxide
levels (59–61). oxyR is negatively autoregulated and its
expression decreases towards the stationary growth













Speciﬁcity Comments Acc. No.
npcRNA candidates antisense to the 30-end of ORF
StyR-143 144 < 1068407 No  /   /  S. typhi, S. para A r-ind. term. FJ746389
StyR-219 104 > 1068601 Yes +/+ +/+ r-ind. term. FJ746397
StyR-250 222 > 1069193 Yes  /   /  FJ746402
npcRNA candidates antisense to the 50-end of ORF
StyR-341 49 > 1070547 No  /   /  Sal. sp FJ746419
npcRNA candidates antisense to both 50- and 30-end of single ORF
StyR-281 253 < 1070369 Yes +/  +/  FJ746407
StyR-47 216 > Predicted ORF Yes  /   /  FJ746385
npcRNA candidates antisense to both 50- and 30-end of ORFs
StyR-328 78 < 1068197 Yes  /   /  FJ746417
StyR-150 46 > 1067798/
1067800
No  /   /  Sal. sp FJ746390
cis-encoded antisense npcRNA candidates to ORFs of protein-coding genes
StyR-101 45 < 1067667 No  /   /  S. typhi FJ746386
StyR-122 25 > 1069722 Yes +/   /  FJ746387
StyR-128 83 < 1069075 Yes  /   /  FJ746388
StyR-151 109 > 1067671 Yes +/   /  FJ746391
StyR-172 57 < 1069704 Yes  /   /  FJ746392
StyR-173 76 < 1068387 No +/  +/  Sal. sp FJ746393
StyR-178 34 < 1067312 Yes  /   /  FJ746394
StyR-196 82 < 1069862 Yes +/  +/  FJ746395
StyR-199 48 > 1067680 Yes +/  +/  FJ746396
StyR-222 75 < 1069061 Yes  /   /  FJ746398
StyR-234 119 > 1069670 Yes +/+ +/+ FJ746399
StyR-243 135 > 1069109 Yes +/  +/  FJ746400
StyR-248 211 > 1070765 Yes +/  +/  FJ746401
StyR-252 162 < 1071079 Yes  /   /  FJ746403
StyR-254 98 < 1071250 Yes +/+ +/  FJ746404
StyR-264 85 > 1067864 Yes +/+  /  r-ind. term. FJ746405
StyR-277 99 > 1069782 Yes  /   /  FJ746406
StyR-285 110 < 1070539 No  /   /  Sal. sp FJ746408
StyR-291 61 > 1070390 Yes  /   /  FJ746409
StyR-292 38 > 1070899 No  /   /  Sal. sp FJ746410
StyR-295 109 > 1066997 Yes  /   /  FJ746411
StyR-302 22 < 1067039 No  /   /  Sal. sp FJ746412
StyR-305 57 < 1067199 No  /   /  FJ746413
StyR-309 32 > 1067690 Yes  /   /  FJ746414
StyR-315 69 < 1069646 Yes  /   /  FJ746415
StyR-322 90 < 1069020 Yes  /   /  FJ746416
StyR-336 199 > 1071148 Yes  /   /  FJ746418
StyR-358 113 < 1067275 No +/  +/  Sal. sp FJ746420
StyR-369 22 < 1067888 No  /   /  Sal. sp FJ746421
StyR-377 23 > 1069015 No  /   /  FJ746422
StyR-378 23 < 1069059 Yes  /   /  Sal. sp FJ746423
npcRNAs, reference identiﬁcations of npcRNA candidates; cDNA (nt), length of cDNA clones in nt; Orient, orientation of npcRNA; Gene (ID), ID
number of protein-coding genes; Presence in E. coli, npcRNA homolog is present (Yes) or not present (No) in the E. coli K12 genome; N. blot
S. typhi/E. coli, northern blots were positive (+) or negative (-) for the given transcript; Growth reg. S. typhi /E. coli, npcRNA was (+) or was not (-)
growth phase-regulated; Speciﬁcity, species speciﬁc; Sal sp, Salmonella species-speciﬁc, S. typhi, S. typhi-speciﬁc, EPEC, enteropathogenic E. coli;
EHEC, enterohemorrhagic E. coli;. Comments: r-ind. term., probable r-independent terminator detected; Acc. No., accession number of npcRNA
sequence in DDBJ/EMBL/GenBank databases.
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StyR-243 expression signiﬁcantly increases during the log
phase and decreases in the stationary phase (Figure 4;
Supplementary Figure S3). In contrast, we did not detect
expression of the putative EcoR-243 homolog in E. coli.
StyR-248 (211nt) is located antisense to part of the tus
ORF, which encodes the DNA replication terminus (ter)
site binding protein. Tus, also known as ter-binding
protein (TBP), binds to ter sites, blocking the progress
of DNA replication in a polar fashion by blocking the
progress of the helicase DnaB, eventually leading to rep-
lication termination (62–64). The ter-bound Tus also
blocks the activity of helicases PriA, Rep and UvrD
(65). StyR-248 is predominantly expressed in the station-
ary phase (Figure 4). This might well reﬂect its possible
role in the control of tus gene expression and replication of
the S. typhi bacterial chromosome. The RNA is highly
conserved in all published Salmonella species genomes
with a putative homolog in E. coli (EcoR-248, 75%
sequence similarity). Inexplicably, StyR-248 gives a
signal of only  80nt on northern blots (Figure 4).
Interestingly, StyR-248 forms a complex with the
S. typhi Hfq protein in vitro, implicating this npcRNA
as a potential riboregulator (Supplementary Data and
Supplementary Figure S4).
StyR-264 (85nt) is expressed complementary to part
of the ORF of the ung gene that encodes the ubiquitous
uracil-DNA glycosylate, an enzyme that prevents muta-
genesis by eliminating uracil from DNA molecules by
cleaving the N-glycosylic bond and initiating the
base-excision repair pathway (66). The expression of
StyR-264 was slightly decreased during the late growth
stage of S. typhi (Figure 4). Expression of the ung
gene was reported to remain constant up to the early sta-
tionary phase of E. coli and to decline in the late station-
ary phase (67). Interestingly, the EcoR-264 homolog
(85nt) exhibits a similar expression pattern (Figure 4),
suggesting that the npcRNA might play a role in
stabilizing Ung mRNA.
To gain further insight into the functional signiﬁcance
of other members of this subclass of antisense npcRNAs,
we investigated their diﬀerential expression proﬁles and
those of the corresponding mRNAs at various growth
stages of S. typhi using real-time PCR (Supplementary
Figure S3). Most of the sense–antisense pairs exhibited
positively co-regulated expression proﬁles, indicating a
possible involvement of antisense npcRNA in stabilizing
cis-encoded mRNAs, probably enhancing their translation
(Supplementary Figure S3).
Class 3: multicopy npcRNAs in S. typhi
We considered npcRNA candidates that were represented
by more than one copy in the S. typhi genome to be re-
petitive (Table 3). Repetitive npcRNAs have been
reported in all three domains of life. For example, four
dispersed long-direct-repeat (LDR) sequences express
both mRNAs (ldrA-D, where the designations A to D
represent four diﬀerent locations in the E. coli genome)
encoding a toxic peptide and their cis-encoded antisense
riboregulators, rdlA-D (68). In addition, six regions in the
E. coli genome display high sequence similarity to the
plasmid hok/sok loci encoding Sok npcRNAs controlling
the sense-orientated protein-coding hok genes (69). We
identiﬁed 11 repetitive npcRNA candidates. Eight
originated from intergenic regions and the other three
were transcribed in antisense orientations to bona ﬁde or
hypothetical genes. Seven of these repetitive npcRNAs
exhibited growth stage-speciﬁc expression patterns
(Figure 5A and B).
StyR-207 perfectly matches an S. typhi locus upstream
from hypothetical protein-coding gene t3891, and at the
same time is complementary to the S. typhi t3892 pseudo-
gene (Figure 5A-c). Based on sequence similarities to
E. coli, these two S. typhi ORFs might represent S. typhi
ldrD and rdlD genes, respectively (Figure 5A-c and B).
Moreover, a sequence similar to StyR-207 was detected
in the S. typhi genome that was complementary to the
hypothetical ORF t2451 (Figure 5A-d). S. typhi ORF
t2451 can be aligned to the E. coli ldrB and rdlB gene
pair (71% sequence similarity; Figure 5A-d). In E. coli,
StyR-207 homologs (EcoR-207) are present in four
copies complementary to rdlA-rdlD npcRNA genes.
Therefore, StyR-207 npcRNAs might represent cis-
encoded riboregulators for rdl npcRNAs, and thereby
play a role in the ldr/rdl toxin–antitoxin system.
StyR-44 and StyR-215 are derived from ribosomal
operons and are each repeated seven times in the
S. typhi and E. coli genomes. Based on the tRNA genes
located in the internal spacer region between 16S and 23S
rRNAs, there are two subtypes of ribosomal RNA
operons deﬁned in many bacterial species (Figure 5A-a
and -b). One subtype features tRNA-Glu and the second
tRNA-Ile and tRNA-Ala in the spacer (70). StyR-44
(109nt) is located upstream of the respective 23S rRNA
genes in all rRNA operons. StyR-215 (62nt) is located
123nt upstream from the 16S rRNA gene in all seven
ribosomal RNA operons (Figure 5A-a and -b). StyR-44
and StyR-215 are both growth rate-regulated and pro-
cessed from longer precursors (Figure 5B). At this point,
Figure 4. Expression analysis of cis-encoded antisense npcRNA candi-
dates at diﬀerent growth stages of S. typhi and E. coli. Northern blot
analyses were performed on total RNA isolated from diﬀerent growth
stages of S. typhi and E. coli at diﬀerent OD600 values, as shown at the
top. OD600 0.3: lag phase-steady bacterial growth; OD600 0.7: log
phase-exponential bacterial growth; and OD600 1.5: stationary growth
phase. The npcRNA candidates and RNA lengths are indicated. As
loading controls, a few examples of ethidium bromide-stained 5S
rRNA are shown.
5902 Nucleic Acids Research, 2010,Vol.38, No. 17we cannot rule out the possibility that both RNAs are
merely metastable RNA intermediates generated during
maturation of ribosomal RNA. Conspicuously, although
StyR-215 was cloned from S. typhi, a northern blot signal
was only detected in E. coli (Figure 5B).
StyR-24 and StyR-103 are both derived from the repeti-
tive IS200 transposon (Figure 5A), of which there are 24
copies in S. typhi. StyR-24 is located 4nt downstream of
the ORF of the transposase gene in the same orientation,
whereas StyR-103 is expressed antisense to the transposase
ORF (Figures 5A, B and 7). RNA-OUT, a cis-endoded
antisese npcRNA to the ORF of the IS10
transposase-encoded gene (RNA-IN), was previously
shown to regulate transposase expression and control
transposition activity in E. coli (71). StyR-103 represents
an abundantly expressed RNA species with pronounced
upregulation during the exponential growth phase
(Figure 5B). Therefore, similar to RNA-OUT, StyR-103
npcRNA may act as a cis-encoding antisense npcRNA to
regulate transposase expression and inﬂuence the rate of
transposition of IS200 elements. This may be the reason
for the extremely low transposition frequency of IS200
during S. typhi growth (72). Indeed, cis-encoded antisense
npcRNA regulation of transposition activity is a wide-
spread phenomenon in prokaryotes (52).
Class 4: S. typhi npcRNAs overlapping with ORFs in the
sense orientation
Twenty-three npcRNA candidates were transcribed in the
same orientation as ORFs and were partially congruent
with the corresponding mRNAs (Table 4). The E. coli t44
npcRNA (135nt) (51) maps upstream of the 30S riboso-
mal protein S2 gene, rpS2, suggesting its role in
attenuating rpS2 expression. StyR-7 appears to be a
putative S. typhi counterpart of the E. coli t44 npcRNA;
however, cDNAs for StyR-7 are up to 238nt long (103nt
longer than t44) covering the S. typhi rpS2 translational
start codon and part of the N-terminus of the ORF
(Supplementary Table S3).
Northern blot analyses revealed growth stage-speciﬁc
expression for ﬁve of the novel npcRNA candidates in
this category (Figure 6). StyR-29 represents another
example of an npcRNA candidate that overlaps the area
of the 50-UTR and a portion of the ORF of the rpsT
ribosomal protein S20 coding gene. Expression of
StyR-29 is a bit complex, as the start of transcription is
located further upstream and complementarily to the
hypothetical t0046 ORF. StyR-29 expression analysis
revealed three distinct transcripts of 77nt, 140nt and
245nt (Figure 6). Our cDNA library contains the
longest (245nt). The 245nt and 77nt transcripts were
speciﬁc to the stationary phase of S. typhi growth. In
contrast, the 140-nt RNA fragment was present through-
out all the growth stages in both S. typhi and E. coli
(Figure 6). Therefore, the three forms of StyR-29 might
regulate expression in multiple modes.
npcRNAs from the S. typhi Pathogenicity Islands
The emergence of pathogenic strains of enteric bacteria
and their adaptation to new environments is accompanied
by the acquisition of foreign DNA segments termed
‘genetic islands’. These islands are arranged as clusters
of genes and encode virulence determinants (11,14). Of
the 97 novel npcRNA candidates discussed, 10 mapped
to SPI regions, suggesting that they might have various
unknown virulence-associated functions (Figure 7).
StyR-327 is located in the intergenic region between
ssaE and sseA of SPI-2 (Figure 7). Sequences similar to
this intergenic region exist in multiple copies in Salmonella
and E. coli species (at least six times in Salmonella species).
We detected terminal A+T-rich inverted repeat sequences
ﬂanking these regions; therefore, the intergenic region













StyR-24 102 26  No  /   /  Downstream from ORF of
IS200 transposase
FJ746424
StyR-44 109 7  Yes +/+ +/+ Part of ribosomal operon FJ746425
StyR-184 84 >22  Yes  /   /  FJ746429
StyR-195 83 >30  Yes +/+  /  FJ746430
StyR-207 122 2  Yes +/+ +/  FJ746431
StyR-327 53 8  No +/  +/  FJ746433
StyR-329 120 >20  Yes +/   /  FJ746434
StyR-215 62 7  Yes +/+ +/+ Upstream to ribosomal operon FJ746432
Antisense repetitive npcRNAs
StyR-90 90 2  Yes +/  +/  FJ746426
StyR-103 108 26  No +/  +/  Antisense to ORF of
IS200 transposase
FJ746427
StyR-137 46 2  Yes +/  +/  Derived from SPI-7 FJ746428
npcRNAs, reference identiﬁcations of S. typhi npcRNA candidates; cDNA (nt), length of cDNA clones in nt; Repeats, number of copies in the S.
typhi TY2 genome (AE014613); Presence in E. coli, npcRNA is present (Yes) or not present (No) in E. coli K12 genome; N. blot S. typhi/E. coli,
northern blots were positive (+) or negative ( ) for the given transcript; Growth phase S. typhi/E. coli, npcRNA was (+) or was not ( ) growth
phase-regulated; Acc. No., accession number of npcRNA sequence in DDBJ/EMBL/GenBank databases.
Nucleic Acids Research, 2010,Vol.38, No. 17 5903harboring StyR-327 might represent a possible miniature
inverted repeat transposable element (MITE) in bacterial
genomes (73). The S. typhi SPI-3 harbors an additional
copy of such an intergenic MITE with sequence similarity
to StyR-327 (Figure 7). Northern blot analysis indicated a
growth stage-speciﬁc expression of StyR-327 (Figure 5B).
Bacterial MITE sequences are predominantly found in
intergenic regions carrying regulatory elements or even
short ORFs fused to pre-existing genes, potentially
changing their regulation or function (73). Thus,
StyR-327 might be a functional riboregulator within a
bacterial MITE sequence.
In addition to three putative npcRNAs in SPI-5
(StyR-24 and StyR-103) and SPI-6 (StyR-341), we
identiﬁed six npcRNAs candidates in SPI-7 (StyR-9,
StyR-101, StyR-137, StyR-143, StyR-161 and StyR-381).
StyR-9 overlaps with the translational start codon of
the hypothetical protein gene t4341, and northern
blot analysis showed growth stage-speciﬁc expression
(Figure 6). The RNA shares 89% sequence similarity
with StyR-10, the latter being conserved in E. coli.
StyR-9 may be a paralog of StyR-10, having originated
via genomic duplication. Interestingly, the two npcRNA
candidates show diﬀerent expression patterns (Figures 2
and 6) and both form speciﬁc RNP complexes with the
S. typhi Hfq protein (Supplementary Data and
Supplementary Figure S4), further indicating that they
might function as riboregulators. StyR-101 and
StyR-137 are cis-encoded in the antisense orientation to
ORFs t4228 and t4317, respectively, suggesting possible
functions in regulating these genes. StyR-161 is restricted
to S. typhi and S. paratyphi C and its transcription is
growth stage-regulated (Figure 2). StyR-381 is constitu-
tively expressed and restricted to S. typhi and S. dublin
Figure 5. Schematic representations and expression analyses of S. typhi repetitive npcRNA candidates. (A) Schematic representations of S. typhi
repetitive npcRNA candidates. Coordinates of depicted genes are based on the completed genome of S. typhi Ty2 (AE014613). Locations of npcRNA
candidates are depicted by red arrows. Known or predicted hypothetical genes are indicated with light blue arrows. Drawings are not to scale.
StyR-24 and StyR-103 npcRNA candidates are each repeated 24 times in the S. typhi genome; only a schematic representation is shown. StyR-44 and
StyR-215 are each repeated seven times in the S. typhi genome; only two rRNA operons are shown (a, b). StyR-207 and its schematic representation
is depicted in (c); green arrow indicates putative S. typhi rdl npcRNA gene (annotated in this study). StyR-207a npcRNA (d) was predicted based on
sequence similarity, putative ldr and rdl genes (annotated in this study) are depicted by blue and green arrows, respectively. (B) Northern blots
showing expression patterns of repetitive npcRNA candidates at diﬀerent growth stages of S. typhi and E. coli.O D 600 values are indicated across the
tops of the blots. OD600 0.3: lag phase-steady bacterial growth; OD600 0.7: log phase-exponential bacterial growth; and OD600 1.5: stationary growth
phase. The npcRNA candidates and RNA lengths are indicated. As loading controls, a few examples of ethidium bromide-stained 5S rRNA are
shown.
5904 Nucleic Acids Research, 2010,Vol.38, No. 17(Figures 2 and 7). These observations suggest that
npcRNAs are prominently represented in and expressed
from pathogenic islands of the bacteria and have poten-
tially diﬀerent functions related to virulence.
CONCLUSION
We present an experimental survey of the small npcRNA
transcriptome in S. typhi that causes typhoid fever.
Ninety-seven novel npcRNA candidates were identiﬁed
and characterized. Northern blot analyses identiﬁed 33
npcRNA candidates that were diﬀerentially expressed
during S. typhi growth. r-Independent transcription ter-
minators and/or promoters were predicted for 10 of the
putative npcRNAs. Most of the npcRNAs were derived
from intergenic (24) or antisense ORF (39) regions.
Phylogenetic analysis predicted that 63 of the novel
putative npcRNA candidates had homologs in E. coli.
Northern blot signals supported the phylogenetic predic-
tions for 19 of these npcRNA homologs, further
implicating their functional signiﬁcance. On the other
hand, three npcRNA candidates were speciﬁc to
S. typhi, while 22 were restricted to Salmonella strains.
Some of these candidates are potentially involved in
host-speciﬁc pathogenicity. Furthermore, we identiﬁed
10 SPI-derived npcRNA candidates that might be
involved in regulatory mechanisms of virulence, antibiotic
resistance pathways or the pathogenic speciﬁcity of
S. typhi. Eleven npcRNA candidates were of repetitive
origin, including possible riboregulators for transposase
and toxin/antitoxin related genes. Thirty-nine of the cis-
encoded npcRNA candidates were transcribed in the anti-
sense orientation to ORFs of protein-coding genes, further
supporting previous observations of widespread sense–
antisense regulatory networks in bacteria. We also
detected small stable npcRNAs candidates overlapping













Speciﬁcity Comments Acc. No.
Partially overlapping with 50-end of ORF
StyR-9 145 > 11 1071490 No +/  +/  S. typhi,S. para C FJ746436
StyR-15 306 > 129 1070087 Yes nd nd Sal. sp. FJ746437
StyR-29 245 < 116 1067535 Yes +/+ +/  FJ746440
StyR-64 108 < 30 1071363 Yes nd nd FJ746443
StyR-77 114 > 49 1069758 Yes nd nd FJ746446
StyR-84 77 < 8 1067059 Yes nd nd FJ746447
StyR-145 327 > 108 1069487 No nd nd S. typhi,S. para C FJ746448
StyR-228 111 > 2 1070302 No  /   /  Sal. sp. FJ746452
StyR-255 243 > 100 1067871 Yes  /   /  FJ746453
StyR-282 86 > 72 1068122 Yes nd nd FJ746457
StyR-296 293 > 71 1069730 Yes +/+ +/+ FJ746454
StyR-335 263 < 97 1069119 Yes  /   /  FJ746455
StyR-364 176 > 77 1067975 Yes nd nd FJ746456
Partially overlapping with 30-end of ORF
StyR-6 159 > 112 1068275 Yes nd nd FJ746435
StyR-26 223 < 150 1067805 Yes nd nd FJ746438
StyR-27 146 > 29 1071267 No +/  +/  FJ746439
StyR-51 87 > 4 1067741 Yes +/+ +/+ FJ746441
StyR-68 95 > 43 1068476 Yes nd nd FJ746444
StyR-74 87 < 12 1069270 Yes nd nd r-ind. term. FJ746442
StyR-76 241 > 112 1069147 Yes nd nd FJ746445
StyR-149 83 > 19 1070930 No nd nd Sal. sp. FJ746449
StyR-165 105 > 40 1069332 Yes nd nd FJ746450
StyR-192 71 > 33 1071394 Yes nd nd r-ind. term. FJ746451
npcRNAs, reference identiﬁcations of S. typhi npcRNA candidates; cDNA (nt), length of cDNA clones in nt; Orient., orientation of npcRNA;
Overlap, number of nucleotides overlapping the ORF; Gene ID, ID of protein-coding genes; Presence in E. coli, npcRNA is present in the E. coli
K12 genome; N. blot S. typhi/E. coli, northern blot was positive (+) or negative ( ) for the given transcript; nd, not done; Growth reg. S. typhi /
E. coli, npcRNA was (+) or was not ( ) growth phase-regulated; Speciﬁcity, species speciﬁcity; Sal sp, Salmonella species speciﬁc; S. typhi, S. typhi
speciﬁc; Comments, r-ind. term., probable r-independent terminator detected; Acc. No., accession number of npcRNA sequence in DDBJ/EMBL/
GenBank databases.
Figure 6. Northern blots showing growth-dependent expression
patterns of S. typhi npcRNA candidates that partially overlap with
ORFs of protein-coding genes. Growth stages of S. typhi and E. coli.
OD600 values are indicated across the tops of the blots. OD600 0.3: lag
phase-steady bacterial growth; OD600 0.7: log phase-exponential bacter-
ial growth; and OD600 1.5: stationary growth phase. The npcRNA
candidates and RNA lengths are indicated. As loading controls, a
few examples of ethidium bromide-stained 5S rRNA are shown.
Nucleic Acids Research, 2010,Vol.38, No. 17 5905with the 50-UTRs of a number of ribosomal
protein-coding genes (individual or organized in an
operon). This could point to an additional layer of regu-
lation during ribosome biogenesis. In vitro binding assays
showed that six of the npcRNA candidates, representing
diﬀerent subgroups, interacted with the S. typhi Hfq
protein, further supporting an important role of Hfq in
npcRNA regulatory networks.
A particularly interesting case is StyR-3 that shares the
promoter region with the ramA gene. We show that RamR,
the transcriptional repressor protein of ramA, interacted
with both the promoter region of ramA and StyR-3
npcRNA. The RNP complex was formed with an
apparent K50 of about 300nM, similar to that of the
observed DNP complex. Moreover, StyR-3 speciﬁcally
competed with RamR protein from the DNP complex.
These ﬁndings point to a potential function of StyR-3
npcRNA in regulating ramA gene expression, which is
associated with MDR in S. typhi. Our ﬁndings set the
stage for further experimentation, to conﬁrm the functions
ofnumerousnovelnpcRNAcandidatesinthepathogenesis




Supplementary Data are available at NAR Online.
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